Q32 Bio Statistics
Total Valuation
Q32 Bio has a market cap or net worth of $18.91 million. The enterprise value is -$27.78 million.
Important Dates
The last earnings date was Thursday, May 8, 2025, before market open.
| Earnings Date | May 8, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Q32 Bio has 12.20 million shares outstanding. The number of shares has increased by 2,268.75% in one year.
| Current Share Class | 12.20M |
| Shares Outstanding | 12.20M |
| Shares Change (YoY) | +2,268.75% |
| Shares Change (QoQ) | +0.14% |
| Owned by Insiders (%) | 0.62% |
| Owned by Institutions (%) | 29.66% |
| Float | 9.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | -4.71 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.71
| Current Ratio | 4.71 |
| Quick Ratio | 4.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -36.80 |
Financial Efficiency
Return on equity (ROE) is -267.20% and return on invested capital (ROIC) is -88.09%.
| Return on Equity (ROE) | -267.20% |
| Return on Assets (ROA) | -33.80% |
| Return on Invested Capital (ROIC) | -88.09% |
| Return on Capital Employed (ROCE) | -97.01% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.39M |
| Employee Count | 43 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Q32 Bio has paid $21,000 in taxes.
| Income Tax | 21,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -94.10% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -94.10% |
| 50-Day Moving Average | 1.86 |
| 200-Day Moving Average | 21.00 |
| Relative Strength Index (RSI) | 40.44 |
| Average Volume (20 Days) | 209,210 |
Short Selling Information
The latest short interest is 703,218, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 703,218 |
| Short Previous Month | 868,525 |
| Short % of Shares Out | 5.77% |
| Short % of Float | 7.20% |
| Short Ratio (days to cover) | 2.28 |
Income Statement
| Revenue | n/a |
| Gross Profit | -48.25M |
| Operating Income | -62.56M |
| Pretax Income | -65.02M |
| Net Income | -59.79M |
| EBITDA | -62.08M |
| EBIT | -62.56M |
| Earnings Per Share (EPS) | -$4.93 |
Full Income StatementBalance Sheet
The company has $65.48 million in cash and $18.80 million in debt, giving a net cash position of $46.68 million or $3.83 per share.
| Cash & Cash Equivalents | 65.48M |
| Total Debt | 18.80M |
| Net Cash | 46.68M |
| Net Cash Per Share | $3.83 |
| Equity (Book Value) | -4.01M |
| Book Value Per Share | -0.33 |
| Working Capital | 54.05M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$65.65 million and capital expenditures -$75,000, giving a free cash flow of -$65.72 million.
| Operating Cash Flow | -65.65M |
| Capital Expenditures | -75,000 |
| Free Cash Flow | -65.72M |
| FCF Per Share | -$5.39 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |